[Editorial] Telemedicine Takes First Step; Innovate Without Catering to Doctors and Pharmacists View original image

Telemedicine, which has been operating as a pilot program, will officially launch this December. Patients will be able to receive medical consultations and prescriptions via video and other means without visiting a medical institution in person. Rules have also been established on eligibility for consultations and prescribing, including a general requirement that patients seeking an initial consultation use a clinic in the same city or province as their residence. We hope this will be an important step toward improving convenience for healthcare consumers and accelerating innovation in related industries.


Medicine delivery remains an issue to be resolved. The government is pursuing a plan to expand eligibility for delivery to all telemedicine patients, but pharmacy groups are strongly opposed. However, if patients must visit a pharmacy to collect their prescriptions after receiving a remote consultation, the system will be only half a measure. For telemedicine to bring meaningful change to healthcare services, inconvenience to patients must be minimized throughout the entire process, from consultation and prescribing to receiving medication.


This is not to suggest that medication safety should be taken lightly. There are concerns about delivery errors, improper storage, and the emergence of delivery-only pharmacies. Patients' identities must be verified and they must receive clear guidance on how to take their medication. Misuse of medicines and excessive commercial interference by platforms must also be prevented. However, these concerns cannot justify blocking the expansion of delivery itself. Rather than limiting themselves to opposition, pharmacy groups should contribute their expertise to building a safe medication delivery system. Any decline in income or other interests of pharmacy professionals must not be used to justify restricting patients' freedom of choice.


The government should first implement delivery within the scope permitted by law and assess its safety and effectiveness. On that basis, it should put in place the necessary legislation and management systems to allow eligibility to be expanded in stages. It should also establish a system for tracking delivery records and responding swiftly to incidents, as well as measures to ensure the secure transmission of electronic prescriptions and protect personal information.



Safety measures are not barriers to medical innovation; they are the foundation that allows it to continue. The standard that determines the future of healthcare must be patients' safety and convenience, not the vested interests of professional groups.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing